Thus, it will be interesting to study the effects of targeting the p55PIK-NF-κB pathway as well as other pathways that regulate KIT expression as potential novel treatments for IMA-resistance in GIST patients. This evidence concerns the gene PIK3R3 and gastrointestinal stromal tumor.